159 related articles for article (PubMed ID: 30429017)
1. LMO7 and LIMCH1 interact with LRIG proteins in lung cancer, with prognostic implications for early-stage disease.
Karlsson T; Kvarnbrink S; Holmlund C; Botling J; Micke P; Henriksson R; Johansson M; Hedman H
Lung Cancer; 2018 Nov; 125():174-184. PubMed ID: 30429017
[TBL] [Abstract][Full Text] [Related]
2. LRIG and cancer prognosis.
Lindquist D; Kvarnbrink S; Henriksson R; Hedman H
Acta Oncol; 2014 Sep; 53(9):1135-42. PubMed ID: 25180912
[TBL] [Abstract][Full Text] [Related]
3. LRIG1 is a prognostic biomarker in non-small cell lung cancer.
Kvarnbrink S; Karlsson T; Edlund K; Botling J; Lindquist D; Jirström K; Micke P; Henriksson R; Johansson M; Hedman H
Acta Oncol; 2015; 54(8):1113-9. PubMed ID: 25813475
[TBL] [Abstract][Full Text] [Related]
4. Expression of LRIG1 and LRIG3 correlates with human papillomavirus status and patient survival in cervical adenocarcinoma.
Muller S; Lindquist D; Kanter L; Flores-Staino C; Henriksson R; Hedman H; Andersson S
Int J Oncol; 2013 Jan; 42(1):247-52. PubMed ID: 23165628
[TBL] [Abstract][Full Text] [Related]
5. Expression of LRIG proteins as possible prognostic factors in primary vaginal carcinoma.
Ranhem C; Lillsunde Larsson G; Hedman H; Lindquist D; Karlsson MG; Hellström AC; Östensson E; Sorbe B; Hellman K; Andersson S
PLoS One; 2017; 12(8):e0183816. PubMed ID: 28841699
[TBL] [Abstract][Full Text] [Related]
6. Leucine-rich repeat and immunoglobulin domain-containing protein-1 (Lrig1) negative regulatory action toward ErbB receptor tyrosine kinases is opposed by leucine-rich repeat and immunoglobulin domain-containing protein 3 (Lrig3).
Rafidi H; Mercado F; Astudillo M; Fry WH; Saldana M; Carraway KL; Sweeney C
J Biol Chem; 2013 Jul; 288(30):21593-605. PubMed ID: 23723069
[TBL] [Abstract][Full Text] [Related]
7. The LRIG family: enigmatic regulators of growth factor receptor signaling.
Simion C; Cedano-Prieto ME; Sweeney C
Endocr Relat Cancer; 2014; 21(6):R431-43. PubMed ID: 25183430
[TBL] [Abstract][Full Text] [Related]
8. In vivo analysis of Lrig genes reveals redundant and independent functions in the inner ear.
Del Rio T; Nishitani AM; Yu WM; Goodrich LV
PLoS Genet; 2013; 9(9):e1003824. PubMed ID: 24086156
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of LRIG proteins in meningiomas: correlation between estrogen receptor status and LRIG expression.
Ghasimi S; Haapasalo H; Eray M; Korhonen K; Brännström T; Hedman H; Andersson U
J Neurooncol; 2012 Jul; 108(3):435-41. PubMed ID: 22484910
[TBL] [Abstract][Full Text] [Related]
10. LRIGs: A Prognostically Significant Family with Emerging Therapeutic Competence against Cancers.
Malik U; Javed A
Curr Cancer Drug Targets; 2017; 17(1):3-16. PubMed ID: 27628597
[TBL] [Abstract][Full Text] [Related]
11. A protein interaction network centered on leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) regulates growth factor receptors.
Faraz M; Herdenberg C; Holmlund C; Henriksson R; Hedman H
J Biol Chem; 2018 Mar; 293(9):3421-3435. PubMed ID: 29317492
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) in HP75 pituitary adenoma cell line.
Guo D; Han L; Shu K; Chen J; Lei T
J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):91-4. PubMed ID: 17393120
[TBL] [Abstract][Full Text] [Related]
13. LRIG1‑2 and LMO7 immunoreactivity in vulvar squamous cell carcinoma: Association with prognosis in relation to HPV‑DNA and p16INK4a status.
Stefansson K; Oda H; Öfverman C; Lundin E; Hedman H; Lindquist D
Oncol Rep; 2019 Jul; 42(1):142-150. PubMed ID: 31059071
[TBL] [Abstract][Full Text] [Related]
14. LIMCH1 suppress the growth of lung cancer by interacting with HUWE1 to sustain p53 stability.
Zhang Y; Zhang Y; Xu H
Gene; 2019 Sep; 712():143963. PubMed ID: 31279706
[TBL] [Abstract][Full Text] [Related]
15. Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors.
Guo D; Nilsson J; Haapasalo H; Raheem O; Bergenheim T; Hedman H; Henriksson R
Acta Neuropathol; 2006 Mar; 111(3):238-46. PubMed ID: 16532360
[TBL] [Abstract][Full Text] [Related]
16. LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix.
Hedman H; Lindström AK; Tot T; Stendahl U; Henriksson R; Hellberg D
Acta Oncol; 2010 Aug; 49(6):812-5. PubMed ID: 20553099
[TBL] [Abstract][Full Text] [Related]
17. LRIG proteins in glioma: Functional roles, molecular mechanisms, and potential clinical implications.
Mao F; Wang B; Xiao Q; Cheng F; Lei T; Guo D
J Neurol Sci; 2017 Dec; 383():56-60. PubMed ID: 29246624
[TBL] [Abstract][Full Text] [Related]
18. HYPOTHESIS: Do LRIG Proteins Regulate Stem Cell Quiescence by Promoting BMP Signaling?
Herdenberg C; Hedman H
Stem Cell Rev Rep; 2023 Jan; 19(1):59-66. PubMed ID: 35969315
[TBL] [Abstract][Full Text] [Related]
19. Lrig1 and Lrig3 cooperate to control Ret receptor signaling, sensory axonal growth and epidermal innervation.
De Vincenti AP; Alsina FC; Ferrero Restelli F; Hedman H; Ledda F; Paratcha G
Development; 2021 Aug; 148(16):. PubMed ID: 34338291
[TBL] [Abstract][Full Text] [Related]
20. Lrig2-deficient mice are protected against PDGFB-induced glioma.
Rondahl V; Holmlund C; Karlsson T; Wang B; Faraz M; Henriksson R; Hedman H
PLoS One; 2013; 8(9):e73635. PubMed ID: 24023893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]